United Therapeutics 10K Form

Sell

50

UTHR
United Therapeutics

Last Price:

367.98

Seasonality Move:

10.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01	10Q	UTHR/United Therapeutics Quarterly
2023-11-01	10Q	UTHR/United Therapeutics Quarterly
2023-08-02	10Q	UTHR/United Therapeutics Quarterly
2023-05-03	10Q	UTHR/United Therapeutics Quarterly
2022-11-02	10Q	UTHR/United Therapeutics Quarterly
2022-08-03	10Q	UTHR/United Therapeutics Quarterly

Receive UTHR News And Ratings

See the #1 stock for the next 7 days that we like better than UTHR

UTHR Financial Statistics

Sales & Book Value

Annual Sales:	$2.33B
Cash Flow:	$300.7M
Price / Cash Flow:	19.56
Annual Sales:	$136.74
Price / Book:	2.63

Profitability

EPS (TTM):	22.77000
Net Income (TTM):	$1.11B
Gross Margin:	$2.07B
Return on Equity:	19.26%
Return on Assets:	16.09%

United Therapeutics Earnings Forecast

Key United Therapeutics Financial Ratios

The Gross Profit Margin over the past 25 years for UTHR is 88.94%.
The Selling, General & Administrative Expenses for UTHR have been equal to 20.50% of Gross Profit Margin.
The Research & Development expenses have been 17.53% of Revenue.
The Interest Expense is 6.02% of Operating Income.
The Net Earning history of UTHR is 42.31% of Total Revenues.
Per Share Earnings over the last 26 years have been positive in 17 years.

United Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	UTHR
CUSIP:	91307C
Website:	unither.com

Debt

Debt-to-Equity Ratio:	0.07
Current Ratio:	4.58
Quick Ratio:	4.2

Price-to-Earnings

Trailing P/E Ratio:	18.13
Forward P/E Ratio:	12.51

UTHR Technical Analysis vs Fundamental Analysis

Sell

50

United Therapeutics (UTHR) is a Sell

Is United Therapeutics a Buy or a Sell?

United Therapeutics stock is rated a Sell
The current United Therapeutics [UTHR] share price is $364.33. The Score for UTHR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.